Signaling Pathways - Cathepsins - Eph Receptors - Angiotensin AT2 Receptors - Sphingosine kinases (SphKs)
清除全部
- B1298 K145Target: Sphingosine kinases (SphKs)Summary: SphK2抑制剂
- B2172 PP121Target: mTOR|Eph Receptors|VEGFR|PDGFR|Bcr-Abl|Src|DNA-PK|P110|HckSummary: 酪氨酸激酶和磷酸肌醇激酶双重抑制剂
- B2206 PD123319Target: Angiotensin AT2 ReceptorsSummary: 血管紧张素AT2受体的拮抗剂
- B2226 SKI IITarget: Sphingosine kinases (SphKs)Summary: 鞘氨醇激酶(SK)抑制剂
- A8683 NVP-BHG712Target: Eph Receptors|VEGFRSummary: EphB4 抑制剂
- A2487 Odanacatib (MK-0822)中文名: 奥当卡替Target: CathepsinsSummary: 组织蛋白酶K抑制剂
- A8239 CA-074 Me7 CitationTarget: CathepsinsSummary: Cathepsin B抑制剂
- A4424 SID 26681509Target: CathepsinsSummary: 人组织蛋白酶L抑制剂
- A4412 MDL 28170Target: Cathepsins|CalpainsSummary: Calpain和cathepsin B抑制剂
- A3717 PF-5431 CitationTarget: Sphingosine kinases (SphKs)Summary: SphK1选择性抑制剂